Your browser doesn't support javascript.
loading
The repertoire of mutational signatures in human cancer.
Alexandrov, Ludmil B; Kim, Jaegil; Haradhvala, Nicholas J; Huang, Mi Ni; Tian Ng, Alvin Wei; Wu, Yang; Boot, Arnoud; Covington, Kyle R; Gordenin, Dmitry A; Bergstrom, Erik N; Islam, S M Ashiqul; Lopez-Bigas, Nuria; Klimczak, Leszek J; McPherson, John R; Morganella, Sandro; Sabarinathan, Radhakrishnan; Wheeler, David A; Mustonen, Ville; Getz, Gad; Rozen, Steven G; Stratton, Michael R.
Afiliação
  • Alexandrov LB; Department of Cellular and Molecular Medicine, Department of Bioengineering, Moores Cancer Center, University of California, San Diego, CA, USA.
  • Kim J; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Haradhvala NJ; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Huang MN; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.
  • Tian Ng AW; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
  • Wu Y; Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore.
  • Boot A; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
  • Covington KR; Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore.
  • Gordenin DA; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
  • Bergstrom EN; Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore.
  • Islam SMA; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
  • Lopez-Bigas N; Centre for Computational Biology, Duke-NUS Medical School, Singapore, Singapore.
  • Klimczak LJ; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
  • McPherson JR; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
  • Morganella S; Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), Durham, NC, USA.
  • Sabarinathan R; Department of Cellular and Molecular Medicine, Department of Bioengineering, Moores Cancer Center, University of California, San Diego, CA, USA.
  • Wheeler DA; Department of Cellular and Molecular Medicine, Department of Bioengineering, Moores Cancer Center, University of California, San Diego, CA, USA.
  • Mustonen V; Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
  • Getz G; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
  • Rozen SG; Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences (NIEHS), Durham, NC, USA.
  • Stratton MR; Programme in Cancer & Stem Cell Biology, Duke-NUS Medical School, Singapore, Singapore.
Nature ; 578(7793): 94-101, 2020 02.
Article em En | MEDLINE | ID: mdl-32025018
ABSTRACT
Somatic mutations in cancer genomes are caused by multiple mutational processes, each of which generates a characteristic mutational signature1. Here, as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium2 of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA), we characterized mutational signatures using 84,729,690 somatic mutations from 4,645 whole-genome and 19,184 exome sequences that encompass most types of cancer. We identified 49 single-base-substitution, 11 doublet-base-substitution, 4 clustered-base-substitution and 17 small insertion-and-deletion signatures. The substantial size of our dataset, compared with previous analyses3-15, enabled the discovery of new signatures, the separation of overlapping signatures and the decomposition of signatures into components that may represent associated-but distinct-DNA damage, repair and/or replication mechanisms. By estimating the contribution of each signature to the mutational catalogues of individual cancer genomes, we revealed associations of signatures to exogenous or endogenous exposures, as well as to defective DNA-maintenance processes. However, many signatures are of unknown cause. This analysis provides a systematic perspective on the repertoire of mutational processes that contribute to the development of human cancer.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mutação / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mutação / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article